- Home
- ATNM vs BOTJ Comparison
ATNM vs BOTJ Comparison
Compare ATNM & BOTJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATNM | BOTJ |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.8M | 90.4M |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ATNM | BOTJ |
|---|---|---|
| Price | $1.14 | $19.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 103.3K | 4.4K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | ★ 30.60 | N/A |
| EPS | N/A | ★ 1.39 |
| Revenue | $81,000.00 | ★ $4,003,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.38 |
| Revenue Growth | N/A | ★ 2.61 |
| 52 Week Low | $1.02 | $13.03 |
| 52 Week High | $1.95 | $21.49 |
Technical Indicators
Market Signals| Indicator | ATNM | BOTJ |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 50.29 |
| Support Level | $1.02 | $17.60 |
| Resistance Level | $1.25 | $21.47 |
| Average True Range (ATR) | 0.07 | 0.43 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 46.51 | 40.00 |
Price Performance
Historical ComparisonAbout ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.